Joe Talamo

Joe Talamo is an experienced financial executive currently serving as Chief Financial Officer at Intensity Therapeutics, Inc. since December 2023. Previously, Joe held the role of Senior Vice President and Chief Financial Officer at HiberCell from August 2020 to November 2023 and served as Senior Vice President and Chief Financial Officer as well as Vice President, Corporate Controller, and Chief Accounting Officer at Caladrius Biosciences from June 2011 to August 2020. Joe's extensive career in finance includes various positions at OSI Pharmaceuticals, including VP & Corporate Controller, and roles at Bristol-Myers Squibb and KPMG, among others. Joe holds an MBA in Finance and a BBA in Accounting, both from Hofstra University.